Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Measurement and prevention of myocardial injury during percutaneous coronary intervention.

× No keyword cloud information.

14 in total

1. Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention.

Authors: John P A Ioannidis; Evangelia Karvouni; Demosthenes G Katritsis
Journal: J Am Coll Cardiol Date: 2003-10-15 Impact factor: 24.094

2. Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study.

Authors: Claudio Cavallini; Stefano Savonitto; Roberto Violini; Gustavo Arraiz; Mario Plebani; Zoran Olivari; Paolo Rubartelli; Salvatore Battaglia; Luigi Niccoli; Giuseppe Steffenino; Diego Ardissino
Journal: Eur Heart J Date: 2005-03-01 Impact factor: 29.983

3. Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) study.

Authors: Giuseppe Patti; Giuseppe Colonna; Vincenzo Pasceri; Leonardo Lassandro Pepe; Antonio Montinaro; Germano Di Sciascio
Journal: Circulation Date: 2005-03-06 Impact factor: 29.690

Review 4. Peri-procedural myocardial injury: 2005 update.

Authors: Joerg Herrmann
Journal: Eur Heart J Date: 2005-09-21 Impact factor: 29.983

5. Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insights from cardiovascular magnetic resonance imaging.

Authors: Joseph B Selvanayagam; Italo Porto; Keith Channon; Steffen E Petersen; Jane M Francis; Stefan Neubauer; Adrian P Banning
Journal: Circulation Date: 2005-02-21 Impact factor: 29.690

6. Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention.

Authors: K M Anderson; R M Califf; G W Stone; F J Neumann; G Montalescot; D P Miller; J J Ferguson; J T Willerson; H F Weisman; E J Topol
Journal: J Am Coll Cardiol Date: 2001-06-15 Impact factor: 24.094

Review 7. Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

Authors:
Journal: Eur Heart J Date: 2000-09 Impact factor: 29.983

8. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study.

Authors: Vincenzo Pasceri; Giuseppe Patti; Annunziata Nusca; Christian Pristipino; Giuseppe Richichi; Germano Di Sciascio
Journal: Circulation Date: 2004-07-26 Impact factor: 29.690

9. Protective effect of an acute oral loading dose of trimetazidine on myocardial injury following percutaneous coronary intervention.

Authors: Laurent Bonello; Pascal Sbragia; Nicolas Amabile; Olivier Com; Sandrine V Pierre; Samuel Levy; Franck Paganelli
Journal: Heart Date: 2007-05-08 Impact factor: 5.994

10. Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment.

Authors: Wai-Hong Chen; Pui-Yin Lee; William Ng; Hung-Fat Tse; Chu-Pak Lau
Journal: J Am Coll Cardiol Date: 2004-03-17 Impact factor: 24.094